BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23532897)

  • 1. Impact of the proline residue on ligand binding of neurotensin receptor 2 (NTS2)-selective peptide-peptoid hybrids.
    Held C; Hübner H; Kling R; Nagel YA; Wennemers H; Gmeiner P
    ChemMedChem; 2013 May; 8(5):772-8. PubMed ID: 23532897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand.
    Held C; Plomer M; Hübner H; Meltretter J; Pischetsrieder M; Gmeiner P
    ChemMedChem; 2013 Jan; 8(1):75-81. PubMed ID: 23097347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics.
    Einsiedel J; Held C; Hervet M; Plomer M; Tschammer N; Hübner H; Gmeiner P
    J Med Chem; 2011 Apr; 54(8):2915-23. PubMed ID: 21446649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
    Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O
    Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based evolution of subtype-selective neurotensin receptor ligands.
    Schaab C; Kling RC; Einsiedel J; Hübner H; Clark T; Seebach D; Gmeiner P
    ChemistryOpen; 2014 Oct; 3(5):206-18. PubMed ID: 25478316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amide linker in nonpeptide neurotensin receptor ligands plays a key role in calcium signaling at the neurotensin receptor type 2.
    Thomas JB; Giddings AM; Olepu S; Wiethe RW; Warner KR; Sarret P; Longpre JM; Runyon SP; Gilmour BP
    Bioorg Med Chem Lett; 2015; 25(10):2060-4. PubMed ID: 25881832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
    Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
    ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.
    Fanelli R; Floquet N; Besserer-Offroy É; Delort B; Vivancos M; Longpré JM; Renault P; Martinez J; Sarret P; Cavelier F
    J Med Chem; 2017 Apr; 60(8):3303-3313. PubMed ID: 28368584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
    Smith KE; Boules M; Williams K; Richelson E
    Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies.
    Gonzalez S; Dumitrascuta M; Eiselt E; Louis S; Kunze L; Blasiol A; Vivancos M; Previti S; Dewolf E; Martin C; Tourwé D; Cavelier F; Gendron L; Sarret P; Spetea M; Ballet S
    J Med Chem; 2020 Nov; 63(21):12929-12941. PubMed ID: 32902268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management.
    Previti S; Desgagné M; Tourwé D; Cavelier F; Sarret P; Ballet S
    J Pept Sci; 2023 Jun; 29(6):e3471. PubMed ID: 36539999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.
    Simeth NA; Bause M; Dobmeier M; Kling RC; Lachmann D; Hübner H; Einsiedel J; Gmeiner P; König B
    Bioorg Med Chem; 2017 Jan; 25(1):350-359. PubMed ID: 27842797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells.
    Sarret P; Gendron L; Kilian P; Nguyen HM; Gallo-Payet N; Payet MD; Beaudet A
    J Biol Chem; 2002 Sep; 277(39):36233-43. PubMed ID: 12084713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
    Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
    J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system.
    Perron A; Sarret P; Gendron L; Stroh T; Beaudet A
    J Biol Chem; 2005 Mar; 280(11):10219-27. PubMed ID: 15637074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
    Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
    Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog.
    Chartier M; Desgagné M; Sousbie M; Rumsby C; Chevillard L; Théroux L; Haroune L; Côté J; Longpré JM; Boudreault PL; Marsault É; Sarret P
    Biomed Pharmacother; 2021 Sep; 141():111861. PubMed ID: 34229249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.
    Chartier M; Desgagné M; Sousbie M; Côté J; Longpré JM; Marsault E; Sarret P
    J Med Chem; 2021 Feb; 64(4):2110-2124. PubMed ID: 33538583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2.
    Thomas JB; Giddings AM; Olepu S; Wiethe RW; Harris DL; Narayanan S; Warner KR; Sarret P; Longpre JM; Runyon SP; Gilmour BP
    Bioorg Med Chem Lett; 2015 Jan; 25(2):292-6. PubMed ID: 25499438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.